CC
Coastlands Capital LP bought $806K of KTTA stock
Coastlands Capital LP, 10% owner of Pasithea Therapeutics Corp. (KTTA), bought 1,667,514 shares of KTTA stock worth $806K, per an SEC Form 4 filed Nov 18, 2026.
It was an open-market purchase.
The trade happened on Nov 13, 2026, 5 days before it was made public.
KTTA has moved -2.1% since the trade date, from $0.52 to $0.51 (Nov 18, 2026 close).
- Traded
- Nov 13, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 5 days
- Price since
- -2.1%
- Role
- 10% owner
- Source
- SEC Form 4